In addition, it would be interesting to include subjects with non-obstructive coronary heart disease and coronary artery stenosis < 50, and assess the association between Gal-3 and other biomarkers such as troponin, CRP and NT-proBNP to further elucidate the underlying pathophysiological mechanism involved in CAD. Here, NPPB is linked to coronary artery disorder.